扩展 Heimler 综合征的临床和遗传谱。
Expanding the clinical and genetic spectrum of Heimler syndrome.
机构信息
Eye Institute, Eye and ENT Hospital, College of Medicine, Fudan University, Shanghai, China.
Shanghai Key Laboratory of Visual Impairment and Restoration, Science and Technology Commission of Shanghai Municipality, Shanghai, China.
出版信息
Orphanet J Rare Dis. 2019 Dec 12;14(1):290. doi: 10.1186/s13023-019-1243-x.
BACKGROUND
Heimler syndrome (HS) is a rare hereditary systemic disorder, partial clinically overlapping with Usher syndrome. So far, our knowledge of HS is very limited, many cases are misdiagnosed or may not even be diagnosed at all. This study aimed to analyze the clinical and genetic characteristics of HS, and to evaluate potential phenotype-genotype correlations.
RESULTS
Two HS cases caused by PEX1 mutations were identified, and a novel likely pathogenic mutation, PEX1 c.895_896insTATA, was found. The main ophthalmic finding of the two patients was consistent with retinitis pigmentosa accompanied by cystoid macular edema, but short axial length and hyperopia were also observed as two previously unreported ocular phenotypes. Analysis of the literature showed that of the 29 HS patients previously reported, 12 had PEX6 mutations, 10 had PEX1 mutations, two had PEX26 mutations, and the remaining patients were not genetically tested. Three novel genotype-phenotype correlations were revealed from analysis of these patients. First, most genotypes of every HS patient include at least one missense variant; second, at least one mutation in PEX1 or PEX6 gene affects the AAA-ATPase region in every HS patient with retinal dystrophy, suggesting AAA-ATPase region is a hypermutable region in patients with a retinal dystrophy; third, there are no significant differences between PEX1-, PEX6-, and PEX26-associated phenotypes.
CONCLUSION
Next-generation sequencing is important for the diagnosis of HS. This study expands the clinical and genetic spectrum of HS, and provides additional insights into genotype-phenotype correlations, which is vital for accurate clinical practice, genetic counseling, and pathogenesis studies.
背景
Heimler 综合征(HS)是一种罕见的遗传性全身疾病,部分临床表现与 Usher 综合征重叠。迄今为止,我们对 HS 的了解非常有限,许多病例被误诊,甚至可能根本没有被诊断出来。本研究旨在分析 HS 的临床和遗传特征,并评估潜在的表型-基因型相关性。
结果
鉴定出两例由 PEX1 突变引起的 HS 病例,并发现了一种新的可能致病性突变 PEX1 c.895_896insTATA。两名患者的主要眼科表现一致,为色素性视网膜炎伴囊样黄斑水肿,但也观察到短轴长和远视,这是两个以前未报道的眼部表型。对文献的分析表明,之前报道的 29 例 HS 患者中,有 12 例为 PEX6 突变,10 例为 PEX1 突变,2 例为 PEX26 突变,其余患者未进行基因检测。从对这些患者的分析中揭示了三个新的基因型-表型相关性。首先,每个 HS 患者的大多数基因型至少包含一个错义变异;其次,每个有视网膜营养不良的 HS 患者中至少有一个 PEX1 或 PEX6 基因突变影响 AAA-ATPase 区域,表明 AAA-ATPase 区域是视网膜营养不良患者的一个高突变区域;第三,PEX1、PEX6 和 PEX26 相关表型之间没有显著差异。
结论
下一代测序对 HS 的诊断很重要。本研究扩展了 HS 的临床和遗传谱,并提供了更多关于基因型-表型相关性的见解,这对于准确的临床实践、遗传咨询和发病机制研究至关重要。
相似文献
Orphanet J Rare Dis. 2019-12-12
Eur J Hum Genet. 2016-11
Am J Med Genet C Semin Med Genet. 2020-9
Ophthalmic Genet. 2018-6
Adv Exp Med Biol. 2020
J Pediatr Ophthalmol Strabismus. 2024
引用本文的文献
BMJ Case Rep. 2024-4-24
Dig Dis Sci. 2024-1
Cold Spring Harb Mol Case Stud. 2021-8
Genes (Basel). 2021-4-26
本文引用的文献
Biochim Biophys Acta Mol Cell Res. 2018-10-23
N Engl J Med. 2018-10-10
N Engl J Med. 2018-10-4
Ophthalmic Genet. 2018-6
Proc Natl Acad Sci U S A. 2018-3-19
Nat Commun. 2018-1-10
Ophthalmology. 2017-12-22
Ophthalmology. 2017-3-22